Clinical trial
Efficacy on Height in SGA Children Treated With Growth Hormone
NCT00184756 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184756 |
|---|---|
| Title | Efficacy on Height in SGA Children Treated With Growth Hormone |
| Official title | Effect of Two Years Treatment With Growth Hormone on Height in SGA Children. |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Foetal Growth Problem, Small for Gestational Age |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 151 |
| Start date | Nov 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 13, 2017 |
| Countries | Czechia, Finland, Germany, Israel, Poland, Portugal, Spain, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: